Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti-Programmed Cell Death 1 Monotherapy for Advanced Non-Small Cell Lung CancerMari Aso, Shunichi Sugawara, Kana Ono et al.|The Oncologist|2019Cited by 59
Association of immune‐related pneumonitis with clinical benefit of anti‐programmed cell death‐1 monotherapy in advanced non‐small cell lung cancerKana Ono, Shunichi Sugawara, Hirotaka Ono et al.|Cancer Medicine|2021Cited by 19
Pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for PD-L1-positive advanced non-small cell lung cancer in the real worldJun Sugisaka, Yasushi Honda, Shunichi Sugawara et al.|Annals of Oncology|2019Cited by 4
Successful Application of Tocilizumab in a Patient With Neoadjuvant Immunochemotherapy‐Induced Cytokine Release SyndromeSoichiro Minami, Shunichi Sugawara, Yosuke Kawashima et al.|Cancer Reports|2024Cited by 3